HCA_AIVITA AV-GBM-1 141-18
Phase II trial of autologous dendritic cells loaded with autologous tumor
associated antigens (AV-GBM-1) as an adjunctive therapy following primary surgery plus
concurrent chemoradiation in patients with newly diagnosed glioblastoma.
PHASE II TRIAL OF AV-GBM-1 (AUTOLOGOUS DENDRITIC CELLS LOADED WITH AUTOLOGOUS TUMOR ASSOCIATED ANTIGENS) AS ADJUNCTIVE THERAPY FOLLOWING PRIMARY SURGERY PLUS CONCURRENT CHEMORADIATION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Michael Duma, M.D.
Aivita Biomedical, Inc.
- Hoag Research
- xSJH Southern California